// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Effectiveness of telephone monitored home exercise for patients with COPD

Lisa Pritchard - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Mechanical insufflation-exsufflation use in neuromuscular disease: A single centre cohort study

Neeraj Shah - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Amyotrophic lateral sclerosis

N/A

Admission Avoidance and Early Supported Discharge with Home Monitoring in COVID-19 Patients

Marcus Anthony Pittman - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Acute exacerbation of COPD patients therapy priorities: A survey study

Bedor Alkhathlan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The impact of COVID-19 shielding on levels of physical activity and health-related quality of life in COPD patients following pulmonary rehabilitation

Emily Hume - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Depression

N/A

To explore the prevalence and impact of hip and/or knee pain in patients presenting for Pulmonary Rehabilitation

Samuel Briggs-Price - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reported outcomes in patients referred with persisting respiratory symptoms following non-hospitalised COVID-19

Theresa Harvey-Dunstan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Depression

N/A

Evaluation of the effectiveness of an outpatient rehabilitation course for patients previously hospitalised with COVID-19

Laura Moth - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Post-COVID and the BHRUT one-stop shop MDT approach to managing the longterm sequale of a novel disease process

Pavan Kumar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

A digitally enhanced pulmonary rehabilitation approach for COPD during COVID-19 using myCOPD

jane stokes - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

A survey to Understand The Need for Rehabilitation Programme After an Episode of COVID-19

Munyra Alhotye - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Utilisation of patient participation and involvement to develop a meaningful educational programme for post COVID-19 rehabilitation

Laura Moth - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

A review of outcomes from a novel long-COVID clinic

Arun Prasad - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The different sensations of breathlessness in patients with COPD- is all breathlessness the same?

Enya Daynes - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

Clinical utility of gait and walking parameters in COPD, a scoping review

Laura Delgado Ortiz - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Effectiveness of multi-disciplinary community respiratory team management of chronic respiratory illness during the COVID-19 pandemic

Emma Johnson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Impact of the British Lung Foundation Active Steps service on patient reported outcomes:  concurrent cohort study

Arwel Jones - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients’ experiences of physical activity

Matthew Armstrong - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Proposed MID in FACIT and VAS scores for individuals attending COVID-19 rehabilitation

Charlotte Gerlis - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The sound of anxiety: exploring the effect of audio recordings of breathing on self-reported breathlessness

Natasha Lovell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Anxiety

N/A

Copyright © 2026. QuantiNova All rights reserved